Ọktoba 28, 2020, SARS-CoV-2 Antigen Rapid Test Kit nke Nanjing Liming Bio-products Co., Ltd. bụ ndị US FDA (EUA) nabatara.Followinggbaso ngwa nchọpụta antigen SARS-CoV-2 nwetara asambodo Guatemala na asambodo Indonesia FDA, nke a bụ ozi ọma ọzọ dị mma.

Ọgụgụ 1 Akwụkwọ ozi nnabata US FDA

Ọgụgụ 2 Asambodo ndebanye aha Indonesian nke SARS-CoV-2 Antigen Rapid Test Kit

Ọgụgụ 3 Guatemala Asambodo nke SARS-CoV-2 Antigen Rapid Test Kit

E jiri ya tụnyere teknụzụ nchọpụta PCR nucleic acid, usoro mgbochi ọrịa dị mfe iji mee ihe n'ọtụtụ ebe n'ihi uru ya ngwa ngwa, adaba na ọnụ ala.Maka nchọpụta ihe mgbochi, oge mpio nke nchọpụta antigen bụ nke mbụ, nke dabara adaba maka nyocha ngwa ngwa n'oge, yana Nucleic acid na nchọpụta antibody dịkwa oke mkpa maka nchọpụta inyeaka ụlọ ọgwụ.

Ntụle uru nke usoro nchọpụta nucleic acid na teknụzụ nchọpụta antigen:

	RT-PCR nchọpụta nucleic acid	Usoro mgbochi ọrịa Antigen Nchọpụta teknụzụ
Mmetụta	Mmetụta ahụ karịrị 95%.Na tiori, n'ihi na nchọpụta nucleic acid nwere ike ịbawanye ndebiri nje virus, nghọta ya dị elu karịa nke ụzọ nchọpụta immunological.	Mmetụta uche sitere na 60% ruo 90%, usoro mgbochi ọrịa chọrọ ihe nlele dị ntakịrị, yana protein antigen kwụsiri ike, yabụ nghọta nke ngwa nchọpụta antigen kwụsiri ike.
Nkọwapụta	karịa 95%	Karịrị 80%
Nchọpụta na-ewe oge	Enwere ike nweta nsonaazụ ule karịa awa 2, na n'ihi akụrụngwa na ihe ndị ọzọ, enweghị ike ịme nyocha ngwa ngwa na saịtị.	Ihe nlele chọrọ naanị nkeji 10-15 iji mepụta nsonaazụ, nke enwere ike nyochaa ngwa ngwa na saịtị.
Ma ọ ga-eji akụrụngwa	Achọrọ akụrụngwa dị oke ọnụ dịka ngwa PCR.	Enweghị akụrụngwa achọrọ.
Ma otu ọrụ	Mba, ha niile bụ ihe atụ ogbe.	Nwere ike.
Nka na ụzụ siri ike nke ọrụ	Mgbagwoju anya ma na-achọ ndị ọkachamara.	Dị mfe ma dị mfe iji rụọ ọrụ.
Ọnọdụ njem na nchekwa	Ụgbọ njem na ụlọ ahịa na mwepu 20 ℃.	Okpomọkụ ụlọ.
Ọnụ ego reagent	Dị oke ọnụ.	Dị ọnụ ala.

Nnwale ngwa ngwa SARS-CoV-2 Antigen

Ngwa nnwale ngwa ngwa SARS-CoV-2